Genmab denies the accusation that it knowingly stole confidential information in a $1.8 billion deal to acquire a cancer drug ...

North Chicago, Ill.-based AbbVie had a loss per share of 2 cents, due to an impairment charge on a drug for schizophrenia and Alzheimer’s-related psychosis, after earnings of 46 cents a share a ...

AbbVie has signed a licensing deal with Danish-based Gubra to develop an obesity drug, marking the North Chicago company's first foray into the obesity market. Gubra will receive $350 million ...

Ciara and Leah Simpson entered a different world when they came to Libertyville High School last April. Their dad’s job transfer with AbbVie to North Chicago meant the Simpsons, who are triplets ...

Another massive pharmaceutical merger is underway. The $63 billion deal combines North Chicago-based AbbVie, which makes the world's best-selling drug Humira, with Dublin-based Allergan ...

AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE� (mirvetuximab soravtansine-gynx) in women with folate ...